| Amal Saki Malehi | 1 Article |
<p>This review compared coronavirus disease 2019 (COVID-19) laboratory findings, comorbidities, and clinical outcomes in patients from the general population versus medical staff to aid diagnosis of COVID-19 in a more timely, efficient, and accurate way. Electronic databases were searched up to 23<sup>rd</sup> March, 2020. The initial search yielded 6,527 studies. Following screening, 24 studies were included [18 studies (11,564 cases) of confirmed COVID-19 cases in the general public, and 6 studies (394 cases) in medical staff] in this review. Significant differences were observed in white blood cell counts (<italic>p</italic> < 0.001), lymphocyte counts (<italic>p</italic> < 0.001), platelet counts (<italic>p</italic> = 0.04), procalcitonin levels (<italic>p</italic> < 0.001), lactate dehydrogenase levels (<italic>p</italic> < 0.001), and creatinine levels (<italic>p</italic> = 0.03) when comparing infected medical staff with the general public. The mortality rate was higher in the general population than in medical staff (8% versus 2%). This review showed that during the early stages of COVID-19, laboratory findings alone may not be significant predictors of infection and may just accompany increasing C-reactive protein levels, erythrocyte sedimentation rates, and lactate dehydrogenase levels. In the symptomatic stage, the lymphocyte and platelet counts tended to decrease. Elevated D-dimer fibrin degradation product was associated with poor prognosis.</p>
Citations
Citations to this article as recorded by
|
|
